RWJBarnabas Health and Rutgers Cancer Institute Welcome First Patients at Melchiorre Cancer Center

Elizabeth and North Jersey residents now have expanded access to world-class cancer care closer to home. RWJBarnabas Health and Rutgers Cancer Institute, the state's only National Cancer Institute-designated Comprehensive Cancer Center, officially welcomed first patients on July 13, 2026, at the newly opened Melchiorre Cancer Center. The facility, located on the campus of Cooperman Barnabas Medical Center in Livingston, represents the latest milestone in RWJBarnabas Health's $1.5 billion investment to transform and expand oncology care across New Jersey.

Union County Life covers Elizabeth healthcare, economic development, and community resources across all 21 Union County municipalities.

Healthcare Access and Geographic Advantage

The new facility addresses a critical healthcare access challenge for North Jersey patients. Historically, residents requiring National Cancer Institute-designated comprehensive cancer care often had to travel significant distances or cross state lines to access such specialized treatment. The Melchiorre Cancer Center brings this level of care to North Jersey, eliminating the need for patients to "drive across a bridge, or through a tunnel" for world-class oncology services.

For Elizabeth residents, the Livingston location represents proximity to specialized cancer care that was previously less accessible. The facility's positioning as "around the corner" rather than a cross-state journey reflects a fundamental shift in healthcare accessibility for the region.

Facility Specifications and Clinical Capabilities

The five-story, 137,000-square-foot, state-of-the-art outpatient facility will serve as the northern hub for oncology services for the health system. The center includes specialized infrastructure for comprehensive cancer treatment: examination rooms, infusion spaces, treatment areas, pharmacy services, and supportive care facilities.

The facility provides patients with access to groundbreaking therapies, clinical trials, and the most advanced treatment options in connection with the Rutgers Cancer Institute. Clinical trials and experimental treatments represent opportunities for patients to access cutting-edge cancer care in partnership with leading research institutions.

National Cancer Institute Designation

The Rutgers Cancer Institute carries the designation as New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center—a distinction reflecting research capabilities, clinical expertise, and institutional commitment to cancer care innovation.

For Elizabeth and North Jersey residents, this designation ensures access to care standards established by the National Cancer Institute and integration with research and clinical trial opportunities.

RWJBarnabas Health Investment

The $1.5 billion investment in cancer care expansion across New Jersey demonstrates RWJBarnabas Health's commitment to oncology infrastructure, workforce, and service expansion. This represents significant capital investment in regional healthcare infrastructure and reflects organizational commitment to meeting patient needs geographically distributed across the state.

Community Statement and Opening

Mark E. Manigan, President and CEO of RWJBarnabas Health, emphasized at the center's opening celebration on June 22 that healthcare access requires meeting patients at their location and time of need. His statement highlighted the importance of eliminating geographic barriers to specialized care—a priority directly relevant to North Jersey residents seeking cancer treatment options.

Steven K. Libutti, MD, FACS, William N. Hait Director of Rutgers Cancer Institute and Senior Vice President of Oncology Services for RWJBarnabas Health, described the center as "a beacon of hope for countless patients and their families." The language reflects the center's role as both clinical facility and community resource for patients facing cancer diagnosis and treatment.

Rick Davis, CEO of Cooperman Barnabas Medical Center, noted the facility's design to "support healing, innovation, and hope—all closer to home." The statement emphasizes geographic proximity as fundamental to the patient experience and healthcare access strategy.

Regional Healthcare Network

The Melchiorre Cancer Center operates as part of RWJBarnabas Health's integrated oncology network, which includes the Jack & Sheryl Morris Cancer Center—the state's first and only freestanding cancer hospital. These facilities reflect institutional strategy to establish New Jersey as a destination for comprehensive cancer care, reducing out-of-state patient migration and supporting residents accessing treatment within state borders.

Elizabeth Healthcare Landscape

For Elizabeth, the Melchiorre Cancer Center represents expanded healthcare infrastructure available to residents. While physically located in Livingston, the facility's accessibility and role in serving North Jersey patients including Elizabeth residents positions it as a community healthcare resource.

Elizabeth residents no longer require travel across state lines or to distant medical centers for NCI-designated comprehensive cancer care. The facility's opening represents healthcare infrastructure expansion directly benefiting Elizabeth and North Jersey communities.

Patient Access and Support Services

The facility design includes not only clinical treatment infrastructure but also supportive services: wellness centers, wig and prosthetic fitting studios, and comprehensive psychological and social support. These services reflect recognition that cancer care extends beyond medical treatment to encompass patient quality of life, dignity, and holistic support during treatment.

For Elizabeth residents, access to comprehensive supportive services represents healthcare system recognition of patient needs beyond clinical intervention—psychosocial, financial, practical, and emotional support integral to cancer care experience.

Moving Forward

The opening of the Melchiorre Cancer Center marks a significant milestone in healthcare infrastructure for North Jersey and Elizabeth residents. As the facility ramps patient volume and integrates into RWJBarnabas Health's oncology network, it will serve as resource for residents facing cancer diagnosis and treatment needs.

For information about the Melchiorre Cancer Center, residents can visit www.rwjbh.org or contact the facility for patient services inquiries and appointment information.

Find more Elizabeth healthcare, economic development, and community resources on Union County Life.

FAQ

Q: What is the Melchiorre Cancer Center?
A: A new state-of-the-art cancer treatment facility on the Cooperman Barnabas Medical Center campus in Livingston that provides NCI-designated comprehensive cancer care for North Jersey residents including Elizabeth.

Q: When did the Melchiorre Cancer Center open?
A: The facility was unveiled June 22, 2026, and officially welcomed first patients July 13, 2026.

Q: Where is the Melchiorre Cancer Center located?
A: On the campus of Cooperman Barnabas Medical Center in Livingston, NJ. It serves North Jersey including Elizabeth residents.

Q: What services does the facility provide?
A: Advanced cancer treatments, clinical trials, multidisciplinary cancer care, supportive services including wellness center and prosthetic fitting studio.

Q: Is the Rutgers Cancer Institute a National Cancer Institute-designated center?
A: Yes. Rutgers Cancer Institute is New Jersey's only NCI-designated Comprehensive Cancer Center, providing access to cutting-edge cancer research and treatment.

Q: Can Elizabeth residents access care at the facility?
A: Yes. The Melchiorre Cancer Center serves North Jersey residents including Elizabeth, providing closer access to specialized cancer care.

Q: What types of treatment are available?
A: Groundbreaking therapies, clinical trials, advanced treatment options, and comprehensive supportive services for cancer patients.

Q: Who operates the Melchiorre Cancer Center?
A: RWJBarnabas Health and Rutgers Cancer Institute jointly operate the facility.

Q: How much did the facility cost?
A: The five-story, 137,000-square-foot facility cost $225 million to construct.

Q: Is this part of a larger health system investment?
A: Yes. The center is part of RWJBarnabas Health's $1.5 billion investment to expand cancer care across New Jersey.